Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-733.74%
operating margin TTM
-777.25%
revenue TTM
79.33 Million
revenue per share TTM
0.96$
valuation ratios | |
|---|---|
| pe ratio | -0.60 |
| peg ratio | 0.05 |
| price to book ratio | 1.06 |
| price to sales ratio | 4.42 |
| enterprise value multiple | -1.04 |
| price fair value | 1.06 |
profitability ratios | |
|---|---|
| gross profit margin | 86.3% |
| operating profit margin | -777.25% |
| pretax profit margin | -733.74% |
| net profit margin | -733.74% |
| return on assets | -69.41% |
| return on equity | -113.4% |
| return on capital employed | -95.0% |
liquidity ratio | |
|---|---|
| current ratio | 3.75 |
| quick ratio | 3.75 |
| cash ratio | 1.70 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 183.74 |
| days of payables outstanding | 452.79 |
| cash conversion cycle | -269.05 |
| receivables turnover | 1.99 |
| payables turnover | 0.81 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.10 |
| debt equity ratio | 0.26 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.21 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -6.00 |
cash flow ratios | |
|---|---|
| free cash flow per share | -2.65 |
| cash per share | 3.27 |
| operating cash flow per share | -2.55 |
| free cash flow operating cash flow ratio | 1.04 |
| cash flow coverage ratios | -6.00 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -23.83 |
Frequently Asked Questions
When was the last time Editas Medicine, Inc. (NASDAQ:EDIT) reported earnings?
Editas Medicine, Inc. (EDIT) published its most recent earnings results on 04-11-2024.
What is Editas Medicine, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Editas Medicine, Inc. (NASDAQ:EDIT)'s trailing twelve months ROE is -113.4%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Editas Medicine, Inc. (EDIT) currently has a ROA of -69.41%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did EDIT's net profit margin stand at?
EDIT reported a profit margin of -733.74% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is EDIT's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.75 in the most recent quarter. The quick ratio stood at 3.75, with a Debt/Eq ratio of 0.26.